SCIONTI PROSTATE CENTER LLC

What SCIONTI PROSTATE CENTER LLC does

Scionti Prostate Center LLC is a single-physician, founder-owned medical practice headquartered at 6600 University Pkwy, Suite 203, Sarasota, Florida, founded by Dr. Stephen Scionti in 2014 to deliver MRI-guided focal therapy for localized prostate cancer. The practice offers four ablation modalities—High Intensity Focused Ultrasound (HIFU), TULSA-PRO transurethral ultrasound ablation, MRI-guided focal cryotherapy, and MRI focal laser ablation—paired with advanced diagnostic services including Artemis MRI-ultrasound fusion targeted biopsy, 3T multiparametric MRI with 3D tumor mapping, and genetic and biomarker screening. Procedures are performed both at the Sarasota office and at Lakewood Ranch Medical Center where the Sonablate system is installed, with on-site and virtual consultations available nationally.

The technology platform combines third-party cleared medical devices (Sonablate from SonaCare Medical and TULSA-PRO from Profound Medical) with proprietary clinical protocols, most notably "Scionti MMM" (MRI Mapped energy Modulated HIFU), a dose-escalation technique layered on top of the Sonablate system to intensify energy delivery over the mapped tumor volume. An internal outcomes registry tracks roughly 700 US patients over four years and has produced published quality benchmarks, including 99% continence at three months, 0% stricture versus 12-15% in published literature, and 100% pad-free rates in the first 80 procedures.

The business operates as an LLC with approximately five employees (founder-physician plus a lead nurse, patient coordinator, and medical concierge). Revenue is generated primarily through one-time procedure fees for HIFU, TULSA-PRO, cryotherapy, and focal laser ablation, supplemented by professional fees for consultations and diagnostic services; Vituro Health assists patients with insurance preauthorization and appeals, while Medicare coverage is partial because Dr. Scionti does not accept Medicare reimbursement directly, leaving many patients to self-pay. The go-to-market combines direct-to-consumer outreach through a website, free case reviews, and content marketing with inbound referrals from a national network of urologists and former patients, leveraging Dr. Scionti's position as the most experienced HIFU physician in the United States (2,000+ HIFU procedures globally since 2006, 200+ TULSA-PRO procedures since 2020, 1,000+ cryotherapy procedures).

Name

SCIONTI PROSTATE CENTER LLC

Legal name

SCIONTI PROSTATE CENTER LLC

Website

https://sciontiprostatecenter.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Scionti Prostate Center is a Sarasota, Florida-based, founder-led urology practice specializing in MRI-guided focal therapies (HIFU, TULSA-PRO, Cryotherapy, Focal Laser Ablation) for men with localized prostate cancer, led by Dr. Stephen Scionti.

Ownership category

akta.pro rank

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Urologic Oncology (HLAKAOAB)

akta.pro secondary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Prostate cancer treatment
• Focal therapy
• HIFU procedures
• MRI-guided biopsy
• Urology services

Headquarters

HQ city

Sarasota

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Revenue model

1. HIFU Procedure Fees: Revenue from High Intensity Focused Ultrasound prostate cancer procedures using Sonablate system
2. TULSA-PRO Procedure Fees: Revenue from TULSA-PRO transurethral ultrasound ablation procedures
3. Cryotherapy Procedure Fees: Revenue from MRI-guided focal cryotherapy procedures with over 25 years of experience
4. Diagnostic Services: Revenue from MRI fusion targeted prostate biopsy, 3D tumor mapping, genetic screening, biomarkers and tumor genomics services
5. Consultation Services: Revenue from initial case reviews and ongoing patient consultations including on-site and virtual options
6. Insurance Reimbursement Assistance: Medicare facility fees covered for HIFU and TULSA-PRO treatments; Vituro Health assists patients with insurance preauthorization and appeals for private insurance

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Scionti Prostate Center is a specialized medical practice offering MRI-guided focal therapies for localized prostate cancer, including HIFU (High Intensity Focused Ultrasound), TULSA-PRO transurethral ultrasound ablation, focal cryotherapy, and MRI focal laser ablation. The center provides advanced diagnostic services such as MRI-guided targeted prostate biopsy using Artemis fusion technology, 3D tumor mapping, and genetic screening with biomarker analysis. Treatment planning is personalized for each patient, with services delivered directly at the Sarasota, Florida center and at affiliated hospital facilities.

Product overview

Scionti Prostate Center is a specialized medical practice offering a comprehensive suite of prostate cancer diagnostic and treatment services centered on MRI-guided focal therapies. The core offerings include HIFU (High Intensity Focused Ultrasound), TULSA-Pro (transurethral ultrasound ablation), Cryotherapy, and MRI Focal Laser Ablation as primary treatment modalities. These are complemented by advanced diagnostic services including MRI-guided targeted biopsy using Artemis fusion technology, 3D tumor mapping, and genetic/biomarker screening. The practice utilizes proprietary techniques such as Scionti MMM (MRI Mapped energy Modulated HIFU) and operates medical devices including the Sonablate system from SonaCare Medical and TULSA-PRO system from Profound Medical. Treatment planning incorporates comprehensive tumor analysis with personalized pathways for each patient, ranging from active surveillance for low-risk cases to targeted focal ablation for clinically significant cancers.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 99% continence rate at 3 months post-procedure
• +4 more outcomes

Named customers8 records

Segments5 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Vituro HealthcoreStrategic or Co-development PartnerDr. Scionti serves as Medical Director for Vituro Health, a teaching and training network for physicians. Vituro Health helps physicians introduce HIFU technology to their communities, brings facilities up to speed with training, and assists patients with insurance reimbursement. Dr. Scionti is Vituro Health's first partner physician and the most experienced HIFU physician in their network.
• SonaCare MedicalcoreTechnology or IntegrationManufacturer of the Sonablate HIFU system, Dr. Scionti's primary workhorse prostate ablation technology. Dr. Scionti previously served as Director of Clinical Education and Training for USHIFU and SonaCare Medical. He was lead proctor for SonaCare's radiation-recurrent clinical trial and has provided feedback for improving Sonablate software and ease of use.
• Profound MedicalcoreTechnology or IntegrationManufacturer of the TULSA-PRO transurethral ultrasound ablation system approved in the US in 2019. Dr. Scionti was the first US urologist to offer TULSA-PRO with over 200 procedures performed. System used for larger prostates with BPH and anterior tumor locations.
• HALO DxcoreStrategic or Co-development PartnerTeaching and training network for physicians where Dr. Scionti serves as Medical Director. Introduces HIFU and other advanced technologies to other urologists through comprehensive training programs.
• NYU Langone Medical Center (Joel E. Smilow Comprehensive Prostate Cancer Center)minorStrategic or Co-development PartnerPrior affiliation where Dr. Scionti served as Clinical Associate Professor of Urology and Director of Prostate Cancer Ablative Surgery. Previously founded Hilton Head, SC International Center for Men's Health.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Cleveland Clinic: Large academic medical center with an established focal therapy program for prostate cancer. Comparable in offering MRI-guided HIFU and other ablation modalities, but with much broader institutional scale and multi-state footprint.
• U.S. Urology Partners: Large urology practice management platform serving multiple states. Comparable as a urology care provider; contrasts as a scaled, PE-backed multi-specialty group offering broader urology services rather than focal-therapy-only specialization.
• NYU Langone Health (Smilow Comprehensive Prostate Cancer Center): Academic prostate cancer center where Dr. Scionti previously served as Director of Prostate Cancer Ablative Surgery. Comparable in offering focal therapy within a larger multi-modality prostate cancer program, with greater institutional scale but broader scope.
• GenesisCare: Large global cancer care provider with significant prostate cancer treatment offerings including radiation and focal therapies. Comparable as a prostate cancer treatment provider, but operates at far greater scale across multiple geographies.

Others

• EDAP TMS: Manufacturer of the Ablatherm HIFU system, a competing prostate ablation device to Sonablate. Public company (EDAP on Nasdaq) operating in the same focal therapy category and historically used by Dr. Scionti.
• Profound Medical: Manufacturer of TULSA-PRO transuretheral ultrasound ablation device used at Scionti. Public company (PROF on Nasdaq) operating in the same focal prostate therapy technology category.
• SonaCare Medical: Manufacturer of the Sonablate HIFU system, Scionti's primary technology platform. Not a direct competitor but the strategic device partner; comparable in its prostate-focused focal therapy ecosystem positioning.

Regional players

• Ackerman Cancer Center: Privately-held specialty prostate cancer treatment center based in Jacksonville, FL. Comparable in its specialty focus on prostate cancer and willingness to adopt advanced modalities, with a regional Southeastern US footprint that partially overlaps Scionti's catchment area.

Direct peers

• Vituro Health: HIFU enablement and treatment network where Dr. Scionti serves as Medical Director. Operates a similar patient-facing focal therapy model and assists with insurance reimbursement, making it the closest comparable in business model.
• HALO Dx: Teaching and training network for physicians introducing HIFU and other advanced urology technologies. Dr. Scionti serves as Medical Director; comparable in its specialty-prostate focus and procedural enablement approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/drscionti
• YouTubeyoutube.com/channel/UCI7OJdah24lpHFx9hR4mXlA
• Facebookfacebook.com/services
• LinkedInlinkedin.com/company/scionti-prostate-center-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCIONTI PROSTATE CENTER LLC